Phase 2 / Phase 3CompletedINTERVENTIONAL
Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole
ClinicalTrials.gov · NCT03440359 · Registry updated: 2018-02-26
- Condition / research focus
- Polycystic Ovary Syndrome
- Sponsor
- Eastern Virginia Medical School
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2012-07-06. Completion: 2017-12-30 (may be estimated). No results posted in this registry response.
Products and interventions (5)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Progesterone Vaginal Gel 8% (drug) — also listed as: Crinone 8% vaginal gel
- Letrozole Oral Tablet (drug)
- pelvic ultrasound (diagnostic_test)
- Ovidrel 250 MCG Per 0.5 ML Prefilled Syringe (drug) — also listed as: recombinant hCG 250 mcg
- Intrauterine insemination or timed intercourse (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.